A fresh and interesting take on kidney care in the United States told from the eyes of a clinician in the field. What is the cost of kidney disease in terms of dollars, suffering, mortality and inefficiencies? Let’s delve into the demographics of those affected by the disease, as well as current market incentive structures. We will then will discuss how after decades of stagnation, there is now a renewed interest in this space by investors and VCs.
Images are licensed under Creative Commons License.
